OFFICIALS LEGISLATION INTEREST GROUPS PUBLIC STATEMENTS COMMITTEES VETOES

Advancing Education on Biosimilars Act of 2021

Floor Speech

Date: April 14, 2021
Location: Washington, DC
Issues: Health and Health Care

Mr. Speaker, I rise today in support of S. 164, the Advancing Education on Biosimilars Act.

This bill is a bipartisan companion to H.R. 1873, championed in the House by Dr. Bucshon and Congressman Peters.

This bill would require the FDA to maintain and operate an internet website to provide educational materials for healthcare providers, patients, and caregivers on biological products, including biosimilar products and interchangeable biosimilar products.

It also would require the Department of Health and Human Services, HHS, to develop continuing education programs or to improve existing programs for healthcare providers, such as doctors and nurses, to promote a better understanding of biosimilar interchangeable products.

By increasing awareness about available biosimilar products and providing educational resources for physicians and patients about their benefits, we can increase adoption of these lower cost alternative therapies when appropriate and drive down drug costs for Americans across the country.

Mr. Speaker, I urge support for this bipartisan effort to lower drug costs through the uptake of biosimilar products, and I reserve the balance of my time.

BREAK IN TRANSCRIPT

Mr. BILIRAKIS. Mr. Speaker, I urge everyone to vote to pass this bill so we can quickly make this law and get it to the President.

BREAK IN TRANSCRIPT


Source
arrow_upward